Genomic Amplification of CCND2 Is Rare in Non-Hodgkin Lymphomas
- 1 April 1998
- journal article
- Published by Elsevier in Cancer Genetics and Cytogenetics
- Vol. 102 (1) , 81-82
- https://doi.org/10.1016/s0165-4608(97)00291-4
Abstract
No abstract availableKeywords
This publication has 7 references indexed in Scilit:
- Deletions of CDKN1B and ETV6 in acute myeloid leukemia and myelodysplastic syndromes without cytogenetic evidence of 12p abnormalitiesGenes, Chromosomes and Cancer, 1997
- Involvement of the TEL Gene in Hematologic Malignancy by Diverse Molecular Genetic MechanismsPublished by Springer Nature ,1996
- Molecular characterization of 12p abnormalities in hematologic malignancies: deletion of KIP1, rearrangement of TEL, and amplification of CCND2Blood, 1996
- Refined mapping of genomic rearrangements involving the short arm of chromosome 9 in acute lymphoblastic leukemias and other hematologic malignanciesBlood, 1995
- Overexpression of cyclin D2 in chronic B-cell malignanciesBlood, 1995
- Cell-cycle regulators and cancerTrends in Genetics, 1995
- The D-type cyclins and their role in tumorigenesisJournal of Cell Science, 1994